Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in patients with myocardial infarction
IRCT20111206008307N42Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin in myocardial infarction (MI), sponsored by Tabriz University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
empagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20111206008307N42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N42.